AIDS

Article	Citations
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	100
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	88
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	79
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	75
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	71
Trends in population HIV viral suppression: a longitudinal analysis	43
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease: a prospective cohort study	43
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	41
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	40
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	39
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	37
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	34
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	32
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	31
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	30
Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance!	29
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals	29
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	29
Real world use of dolutegravir two drug regimens	29
Hepatitis delta in patients hospitalized in Spain (1997–2018)	28
Social context and tracing household wealth over time in rural Uganda 1994–2018	27
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	26
Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries	26
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	26
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis	24

Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy	24
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	24
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	24
Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV	23
Life expectancy of people with HIV on antiretroviral therapy in Spain	23
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors	23
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	23
The relationship between alcohol consumption and risk of HIV in married men in Sub-Saharan Africa	22
Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV	22
Cardiovascular outcomes among persons with HIV and nonalcoholic fatty liver disease	22
Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen	22
‘Zombie’ proviruses in the spotlight: exploring the dark side of HIV persistence	21
Association between low bone mass and fracture prevalence among children living with HIV in Africa	21
Do women with HIV, diabetes mellitus, and full antiretroviral therapy adherence have a lower rate of HIV viremia than men?	21
Association of T-cell subtypes with macrophage-specific arterial infiltration in people with HIV	21
Fatty liver disease in children living with HIV: a ghostly iceberg	20
Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV	20
Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa	20
Anal neoplasia: prevention or treatment?	20
Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi	20
Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort	20
Incident depression among Medicare beneficiaries with disabilities and HIV	20
Hiv and herpes simplex virus 2 incidence among adolescent girls and young women who sell sex (YWSS) in rural south africa: a population-based cohort study	20
Age-associated dementia among older people aging with HIV in the United States: a modeling study	20
Osteopontin as a potential mediator of inflammation in HIV and comorbid conditions	19
What we have learned from antiretroviral treatment optimization efforts over the last 5 years?	19
Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV	19
Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings	19
Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV	18
Using molecular epidemiology to trace the history of the injection-related HIV epidemic in New York City, 1985–2019	18
Increased risk of false-positive HIV ELISA results after COVID-19	18
The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the pre-randomization phase of a clinical trial	17
What happened with preexposure prophylaxis uptake among female sex workers in Zimbabwe? Implications for future prevention programmes	17
An agricultural livelihood intervention is associated with reduced HIV stigma among people with HIV	17
Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa	17
A point-of-care tenofovir urine test improves accuracy of self-reported preexposure prophylaxis adherence and increases condomless sex reporting among young women	17
Inferring population HIV incidence trends from surveillance data of recent HIV infection among HIV testing clients	17
Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally	17
Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection	16
Bictegravir/emtricitabine/tenofovir alafenamide after virologic failure to cabotegravir/rilpivirine	16
Ambient air pollution is associated with vascular disease in Ugandan HIV-positive adolescents	16
Prevalence and resistance patterns of Mycoplasma genitalium infection in people living with HIV: a systematic review and meta-analysis	16
‘With age comes wisdom’: effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV	16
Prevalence and incidence of human papilloma virus-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people with HIV	16
Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes	15
Coordination of inflammatory responses in children with perinatally acquired HIV infection	15
HIV and race are independently associated with endothelial dysfunction	15
Sexually transmitted infections in the preexposure prophylaxis era	15
Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation	15
An overview of programmatic indicators to monitor the roll-out of HIV preexposure prophylaxis	15

Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis	15
Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation	15
Children who are HIV-exposed and uninfected: evidence for action	15
Potential HIV/ART-mediated germline mutations causing congenital inborn errors of immunity in children born to HIV+ couples: an alarming spectre	15
Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus	15
Obesity in HIV infection: host-pathogen interaction	15
Local microbiota dysbiosis contributes to the development of high-risk human papillomavirus-associated anal squamous cell carcinoma	14
A note of thanks to our reviewers	14
Addressing atherosclerotic cardiovascular disease risk in persons with HIV	14
Predictors of intact HIV DNA levels among children in Kenya	14
FDG PET/computed tomography can detect region-specific neuronal changes following antiretroviral therapy in HIV-infected patients	14
The relationship between HIV and reading performance for children in Tanzania	14
Higher CCR5 density on CD4+ T-cells in mothers and infants is associated with increased risk of in-utero HIV-1 transmission	14
Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy	14
Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial	14
Not all clusters are equal: dynamics of molecular HIV-1 clusters in a statewide Rhode Island epidemic	14
Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia	14
Brain N-acetyl-aspartyl-glutamate is associated with cognitive function in older virally suppressed people with HIV	14
Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support	14
Altered mitochondrial mass and fatty acid uptake by NK cells in HIV-exposed uninfected children at 6 years of age	13
Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries	13
Racial/ethnic disparities in estimated undiagnosed HIV infection among adolescents and adults in the United States, 2017–2021	13
Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response	13
Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America	13
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort	13
Poverty and protection: the relationship between multidimensional poverty, social protections interventions, and HIV viral load	13
The cumulative prevalence of HIV-1 drug resistance in perinatal HIV	13
Association of CD4+ cell count and HIV viral load with risk of non-AIDS-defining cancers	12
Hazardous alcohol consumption is associated with an increased occurrence of falls among people with HIV in the PROSPER-HIV Study	12
Racial disparities in cancer risk among MSM with HIV in the United States	12
The incidence and dynamic risk factors of chronic kidney disease among people with HIV	12
Housing is harm reduction	12
Cerebrospinal fluid viral escape can provide clues for the management of HIV-associated neurologic complications: Highlights from the 2023 American Academy of Neurology Annual Meeting, Boston	12
The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017	12
Dolutegravir regimens have transformed treatment, but ongoing drug resistance research is required to maintain success	12
Association between low skeletal muscle mass and lung function decline in people with HIV: a prospective cohort study	12
Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?	12
Initial antiretroviral therapy regimen and risk of heart failure: Erratum	12
Risk score prediction for bacteriologically confirmed tuberculosis among adults with HIV on antiretroviral therapy in northwest Ethiopia: prognostic model development	12
Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence	12
Global health solidarity in the HIV and hypertension disease response	12
Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV	12
Perinatal HIV infection is associated with deficits in muscle function in children and adolescents in Zimbabwe	12
Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infection	12
Auditory and cognitive function in older adults living with and without HIV	12
Identification of a novel HIV-1 second-generation circulating recombinant form (CRF136_0107) among MSM in China	11
Caregiver fears and assumptions about child HIV status drive not testing children for HIV	11
A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders	11
A new smoking cessation ‘cascade’ among women with or at risk for HIV infection	11
Risk and predictors of penile cancer in US Veterans with HIV	11
Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV	11
Adolescent girls and young adult women's HIV infection, male partner age, and HIV status: connecting the dots	11
Is it time to retire efavirenz as a first-line option worldwide?	11
First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort	11
Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a ‘miR’-velous opportunity of early diagnosis?	11
When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV	11
Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection	11
COVID-19 in Africa: preexisting immunity and HIV	10
HIV-positive Ukrainian refugees in the Czech Republic	10
Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs	10
Global variations in pubertal growth spurts in adolescents living with perinatal HIV	10
Home-based HIV testing strategies for middle-aged and older adults in rural South Africa	10
Self-injurious unnatural death among Veterans with HIV	10
Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats	10
Associations between HIV serostatus and coronary artery plaque volume progression	10
Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc	10
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV	10
Impact of a livelihood intervention on gender roles and relationship power among people with HIV	10
Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States	10
Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals: Erratum	10
Fungal diseases are not in the radar of main international HIV conferences	10
Cervical cancer screening in women living with HIV: an audit of clinical care	10
Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period	10
Epstein–Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS	10
HIV and mpox: a rapid review	10
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes	10
The application of new metrics for understanding trends in undiagnosed HIV among key populations	10
Deciphering HIV vaccine-induced antibody response according to ethnicity	9
Intracranial vascular imaging detects arterial wall abnormalities in persons with treated HIV infection	9
Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?	9

Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption	9
The HIV-2 proviral landscape is dominated by defective proviruses	9
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in adults with HIV	9
Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV	9
Use of tenofovir-based preexposure prophylaxis among pregnant women in South Africa	9
Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3	9
Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population	9
Addressing the burden of HIV-associated chronic lung disease in West Africa	9
Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy	9
Needs for shelter or housing assistance among people with diagnosed HIV by jurisdiction: United States, 2015–2020	9
Cytokines in HIV infection: authors’ reply	9
Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa	9
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV	9
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression	9
Transplantation of kidneys from donors with HIV: are we there yet?	9
HIV-positive donor hearts – a game changer for patients with HIV and organ failure?	9
Skeletal muscle mitochondrial dysfunction in contemporary antiretroviral therapy: a single cell analysis	9
Cardiovascular risk score associations with frailty in men and women with or at risk for HIV	9
Abnormal cognitive aging in people with HIV: evidence from data integration between two countries’ cohort studies	9
Factors associated with survival in patients with lymphoma and HIV	9
Association of urine biomarkers of kidney health with subclinical cardiovascular disease among men with and without HIV	9
Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk	9
Initial antiretroviral therapy regimen and risk of heart failure	9
Food insecurity likely contributes to frailty in people with HIV	9
Clinical decision support systems to guide healthcare providers on HIV testing	8
Care interruptions and mortality among adults in Europe and North America	8
Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice	8
Years of life lost to cancer among the United States HIV population, 2006–2015	8
Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa	8
Cost-effectiveness of different intervention strategies of HIV in Zhejiang, China	8
Enhance harm reduction programmes in responding to the changing trend of drug use and HIV transmission in Asia and the pacific	8
Assessing layered HIV prevention programming: optimizing outcomes for adolescent girls and young women	8
Brain RNA profiling highlights multiple disease pathways in persons with HIV-associated neurocognitive disorder	8
Maternal–foetal transfer of severe acute respiratory syndrome coronavirus 2 antibodies among women with and those without HIV infection	8
TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection	8
Dolutegravir-induced neural tube defects in mice are folate responsive	8
New preexposure prophylaxis options need updated counseling approaches: reframing ‘risk’ in HIV prevention counseling for young sexual and gender minorities of color	8
Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?	8
Distinct antibody profiles in HLA-B ∗ 57 + , HLA-B ∗ 57 − HIV controllers and chronic progressors	8
The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa	8
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy	8
Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIV	8
The lipid research clinics physical activity questionnaire does not accurately measure physical activity in people with HIV	8
Incidence of high blood pressure among Kenyan adults with HIV	8
Acute retroviral syndrome is associated with lower CD4+ T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiation	8
Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa	8
Brain aging and cardiovascular factors in HIV: a longitudinal volume and shape MRI study	8
A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West Africa	8
Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries	8
Plasma d-amino acids are associated with markers of immune activation and organ dysfunction in people with HIV	8
Contribution of HIV transmission bursts to future HIV infections, United States	8
Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action	8
Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV	8
Sparse data obscure an unchecked Russian HIV epidemic	8
Immediate virological failure with intramuscular cabotegravir–rilpivirine in a patient long suppressed with dolutegravir–rilpivirine	8
Cabotegravir–rilpivirine treatment initiation in a nonvirologically suppressed patient	8
Quantifying the association of individual-level characteristics with disparities in kidney transplant waitlist addition among people with HIV	8
Baseline HIV drug-resistance testing: 12 US jurisdictions, 2014–2019	8
Intersectional stigmas are associated with lower viral suppression rates and antiretroviral therapy adherence among women living with HIV	7
Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors’ reply	7
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens	7
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy	7
Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication	7
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV	7
Left behind? A longitudinal analysis of need for PrEP services among middle-aged and older adults in South Africa	7
Association between HIV and cancer risk: a nationwide, population-based cohort study	7
Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status	7
Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass	7
Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV	7
AIDS: changes in leadership	7
Keeping up with Streptococcus pneumoniae in children living with HIV	7
Mitochondrial dysfunction in people with HIV receiving contemporary antiretroviral therapy	7
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV	7
Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy	7
Differential genome-wide associated variants and enriched pathways of ECG parameters among people with versus without HIV	7
Cost of improved test and treat strategies in Indonesia	7
HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks	7
From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017–2020	7
Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy	7
Association between tight junction proteins and cognitive performance in untreated persons with HIV	7
Deconvoluting the contribution of antiretroviral choice in weight gain	7
Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment	7
Changes in short-term (in-ICU and in-hospital) mortality following intensive care unit admission in adults living with HIV: 2000–2019	7
Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk?	7
The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions	7
Human herpes virus 8-related illness: still with us	7
Individual and household factors associated with non-disclosure of positive HIV status in a population-based HIV serosurvey	7
What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?	7
Neurologic infections in people with HIV: shifting epidemiological and clinical patterns	7
Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study	7
Weight loss associated with semaglutide treatment among people with HIV	7
Sexual behaviours and risk with women in MSM in sub-Saharan Africa	7
Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV – United States, May 2015–June 2020	7
Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa	7
Variability in the relationships between auditory processing and neurocognitive status among older adults with HIV	6